Top compounds associated with response to USE1


Feature Type Standardized
Nominal ANOVA
mRNA KW-2449 CTRPv2 pan-cancer AAC 0.067 0.04
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.074 0.04
mRNA NG-25 GDSC1000 pan-cancer AAC 0.064 0.04
mRNA CP466722 GDSC1000 pan-cancer AAC 0.064 0.04
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC -0.11 0.04
mRNA Erlotinib CCLE pan-cancer AAC -0.094 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.11 0.05
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.07 0.05
Download CSV